{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:04:25Z","timestamp":1792548265325,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cbi.2022.109901","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T18:09:51Z","timestamp":1648145391000},"page":"109901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions"],"prefix":"10.1016","volume":"358","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-3628","authenticated-orcid":false,"given":"Nidhi","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-9616","authenticated-orcid":false,"given":"Ajmer Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-3142","authenticated-orcid":false,"given":"Viney","family":"Lather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-4945","authenticated-orcid":false,"given":"Suresh Kumar","family":"Gahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cbi.2022.109901_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1368-7646(03)00059-1","article-title":"Drug resistance and the microenvironment: nature and nurture","volume":"6","author":"Morin","year":"2003","journal-title":"Drug Resist. Updates"},{"issue":"8","key":"10.1016\/j.cbi.2022.109901_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrc1671","article-title":"Using Drosophila melanogaster to map human cancer pathways","volume":"5","author":"Brumby","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cbi.2022.109901_bib4","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1038\/s41598-018-23768-7","article-title":"Virtual screening, docking, ADMET and system pharmacology studies on garcinia caged xanthone derivatives for anti-cancer activity","volume":"8","author":"Alam","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cbi.2022.109901_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.6026\/97320630011322","article-title":"Molecular docking based screening of novel designed chalcone series of compounds for their anti-cancer activity targeting EGFR kinase domain","volume":"11","author":"Rao","year":"2015","journal-title":"Bioinformation"},{"issue":"4","key":"10.1016\/j.cbi.2022.109901_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s43440-020-00131-0","article-title":"Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance","volume":"72","author":"Maity","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2022.109901_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/526963","article-title":"Anti-EGFR therapy: mechanism and advances in clinical efficacy in breast cancer","author":"Flynn","year":"2009","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.cbi.2022.109901_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.annepidem.2005.02.004","article-title":"Medicinal plants: historical and cross-cultural usage patterns","volume":"15","author":"Halberstein","year":"2005","journal-title":"Ann. Epidemiol"},{"key":"10.1016\/j.cbi.2022.109901_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2016.08.006","article-title":"Bioactive natural products in cancer prevention and therapy: progress and promise","volume":"40\u201341","author":"Bishayee","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cbi.2022.109901_bib10","first-page":"14","article-title":"Medicinal plants, a gold mine of anti-cancer compounds","volume":"9","author":"Das","year":"2015","journal-title":"Am Int J Res Formal Appl Nat Sci"},{"key":"10.1016\/j.cbi.2022.109901_bib11","article-title":"Alkaloids isolated from natural herbs as the anti-cancer agents. Evid. Based Complement","author":"Lu","year":"2012","journal-title":"Alternative Med."},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/medicines2030251","article-title":"Modes of action of herbal medicines and plant secondary metabolites","volume":"2","author":"Wink","year":"2015","journal-title":"Medicines"},{"key":"10.1016\/j.cbi.2022.109901_bib13","series-title":"Alkaloids - Secrets of Life: Alkaloid Chemistry, Biological Significance, Applications and Ecological Role","author":"Aniszewski","year":"2007"},{"issue":"1","key":"10.1016\/j.cbi.2022.109901_bib14","first-page":"46","article-title":"Alkaloids as anti-cancer agents","volume":"1","author":"Mohan","year":"2012","journal-title":"Ann. Phytomed."},{"issue":"22\u201324","key":"10.1016\/j.cbi.2022.109901_bib15","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.phytochem.2007.07.009","article-title":"Evolution and current status of the phytochemistry of nitrogenous compounds","volume":"68","author":"Zenk","year":"2007","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.cbi.2022.109901_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/molecules22020250","article-title":"Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms","volume":"22","author":"Habli","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.109901_bib17","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2022.109901_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"D1","key":"10.1016\/j.cbi.2022.109901_bib19","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.cbi.2022.109901_bib20","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.109901_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-4939-6952-4_20","article-title":"AutoDock and AutoDockTools for protein-ligand docking: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study","volume":"1598","author":"El-Hachem","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.cbi.2022.109901_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2022.109901_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.cbi.2022.109901_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein data bank (PDB): the single global macromolecular structure archive","volume":"1607","author":"Burley","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2022.109901_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ed100697w","article-title":"ChemSpider: an online chemical information resource","volume":"87","author":"Pence","year":"2010","journal-title":"J Chem. Educ."},{"key":"10.1016\/j.cbi.2022.109901_bib26","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cbi.2022.109901_bib27","first-page":"447","article-title":"Screening of selected ethno-medicinal plants for anti-cancer activity","volume":"8","author":"Dongre","year":"2020","journal-title":"Adv Zool Bot"},{"key":"10.1016\/j.cbi.2022.109901_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biopha.2018.03.071","article-title":"Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and\/or inhibiting NF-\u03baB signaling or PI3K\/AKT\/mTOR pathway","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cbi.2022.109901_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/cbdd.13621","article-title":"Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin\u2010resistant ovarian cancer (A2780) cells","volume":"95","author":"Sarkhosh\u2010Inanlou","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2022.109901_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.freeradbiomed.2019.01.039","article-title":"Critical role of H2O2 in mediating sanguinarine-induced apoptosis in prostate cancer cells via facilitating ceramide generation, ERK1\/2 phosphorylation, and Par-4 cleavage","volume":"134","author":"Rahman","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"13","key":"10.1016\/j.cbi.2022.109901_bib31","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/molecules25133045","article-title":"The synergistic effect of piperlongumine and sanguinarine on the non-small lung cancer","volume":"25","author":"Ha\u0142as-Wi\u015bniewska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.109901_bib32","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.2147\/CMAR.S212744","article-title":"Sanguinarine exhibits potent efficacy against cervical cancer cells through inhibiting the STAT3 pathway in vitro and in vivo","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.cbi.2022.109901_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11418-019-01330-7","article-title":"Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p\/miR-29c-3p and the MAPK\/JNK signaling pathway","volume":"73","author":"Dong","year":"2019","journal-title":"J. Nat. Med."},{"issue":"24","key":"10.1016\/j.cbi.2022.109901_bib34","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2174\/1381612824666180829100601","article-title":"The anti-cancer effect of sanguinarine: a review","volume":"24","author":"Fu","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"issue":"1","key":"10.1016\/j.cbi.2022.109901_bib35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12885-018-4463-x","article-title":"Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK","volume":"18","author":"Gong","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2022.109901_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fphar.2018.00136","article-title":"Molecular determinants of sensitivity or resistance of cancer cells toward sanguinarine","volume":"9","author":"Saeed","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib37","first-page":"85","article-title":"Untapped potential of the indigenous anti-cancer biodiversity in the Indo-Himalayan hotspot","volume":"6","author":"Pathak","year":"2019","journal-title":"Int. J. Pharmacogn."},{"issue":"2","key":"10.1016\/j.cbi.2022.109901_bib38","article-title":"Tinospora cordifolia: a multipurpose medicinal plant- a review","volume":"2","author":"Mittal","year":"2014","journal-title":"J. Med."},{"issue":"11","key":"10.1016\/j.cbi.2022.109901_bib39","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/biom10111532","article-title":"Magnoflorine-isolation and the anti-cancer potential against NCI-H1299 lung, MDA-MB-468 breast, T98G glioma, and TE671 rhabdomyosarcoma cancer cells","volume":"10","author":"Okon","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7732\/kjpr.2014.27.3.223","article-title":"Potential biological activities of magnoflorine: a compound from Aristolochia debilis Sieb. et Zucc","volume":"27","author":"Li","year":"2014","journal-title":"Korean J. Polar Res."},{"issue":"9","key":"10.1016\/j.cbi.2022.109901_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02437","article-title":"The chemical constituents and diverse pharmacological importance of Tinospora cordifolia","volume":"5","author":"Sharma","year":"2019","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.26444\/jpccr\/127326","article-title":"Magnoflorine-a compound with anti-tumor activity","volume":"14","author":"Baran","year":"2020","journal-title":"J Pre Clin Clin Res"},{"key":"10.1016\/j.cbi.2022.109901_bib43","series-title":"Toxicological Survey of African Medicinal Plants","first-page":"611","article-title":"Health effects of alkaloids from African medicinal plants","author":"Kuete","year":"2014"},{"issue":"6","key":"10.1016\/j.cbi.2022.109901_bib44","first-page":"1031","article-title":"Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-kappaB signaling","volume":"10","author":"Manu","year":"2009","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"2","key":"10.1016\/j.cbi.2022.109901_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbi.2013.09.007","article-title":"Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo","volume":"206","author":"Saraswati","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.109901_bib46","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1007\/BF02895996","article-title":"Hypoglycemic activity of jatrorrhizine","volume":"25","author":"Yan","year":"2005","journal-title":"J Huazhong Univ Sci Tech Med Sci"},{"issue":"11","key":"10.1016\/j.cbi.2022.109901_bib47","first-page":"2718","article-title":"Antioxidative and cytotoxic activities of crude and isolated compounds of P. Lateriflora (bl.) King","volume":"10","author":"Obaid","year":"2018","journal-title":"J. Pharmaceut. Sci. Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7150\/ijbs.23247","article-title":"Role of plant derived alkaloids and their mechanism in neurodegenerative disorders","volume":"14","author":"Hussain","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.cbi.2022.109901_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1389203718666170106103031","article-title":"Alkaloids as cyclooxygenase inhibitors in anti-cancer drug discovery","volume":"19","author":"Hashmi","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.cbi.2022.109901_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/485042","article-title":"Alkaloids isolated from natural herbs as the anticancer agents","author":"Lu","year":"2012","journal-title":"Evid Based Complement Alternat Med 2012"},{"key":"10.1016\/j.cbi.2022.109901_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576559","article-title":"P-glycoprotein: one mechanism, many tasks and the consequences for pharmacotherapy of cancers","volume":"10","author":"Seelig","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2022.109901_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1081\/DMR-120026871","article-title":"Clinical relevance of P-glycoprotein in drug therapy","volume":"35","author":"Lin","year":"2012","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2022.109901_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1389450003349443","article-title":"P-glycoprotein as a drug target in the treatment of multidrug resistant cancer","volume":"1","author":"Lehne","year":"2000","journal-title":"Curr. Drug Targets"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:07:30Z","timestamp":1757858850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":53,"alternative-id":["S0009279722001065"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109901","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109901"}}